Filing
Spy
Filing
Spy
Home
About
MRK
Merck & Co., Inc.
Global research-intensive biopharmaceutical company
CUSIP: 589331107
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2016 Q4
21 of 35 quarters
Total Value
$56.09B
Total Shares
952.7K
Net Share Change
-5.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Kahn Brothers Group
$56.09B
952.7K
9.5%
TRIM
-5.3K
(-0.5%)
Kahn Brothers Group
$56.09B
952.7K shares
TRIM
-5.3K
(-0.5%)
MRK — Merck & Co., Inc. - FilingSpy